申请人:UNIVERZA V LJUBLJANI, FAKULTETA ZA FARMACIJO
公开号:EP1845083A3
公开(公告)日:2009-12-30
This invention belongs to the field of pharmaceutical chemistry and relates to new arylsulfonohydrazides as inhibitors of UDP-N-acetylmuramyl:L-alanine ligaze (MurC) and UDP-N-acetylmuramyl-L-alanine:D-glutamate ligaze (MurD), to procedures for their preparation and pharmaceutical preparations containing the same. The enzymes MurC and MurD are the key enzymes involved in the synthesis of bacterial peptidoglycan, so arylsulfonohydrazide inhibitors possess antibacterial activity. Compounds of general formula I
and the pharmaceutically acceptable salts are described. The appropriate substituents are clearly presented in the body of the text and in claims.
这项发明属于药物化学领域,涉及新的芳基磺酰肼作为UDP-N-乙酰基葡萄糖胺基莫拉酰基:L-丙氨酸连接酶(MurC)和UDP-N-乙酰基葡萄糖胺基-L-丙氨酸:D-谷氨酸连接酶(MurD)的抑制剂,以及它们的制备方法和含有相同物质的药物制剂。酶MurC和MurD是参与细菌肽聚糖合成的关键酶,因此芳基磺酰肼抑制剂具有抗菌活性。描述了一般式I的化合物及其药用盐。适当的取代基在文本主体和权利要求中清晰呈现。